Results
1 -
10 of
59Evidence for host resistance in 1,3 bis(2-chloroethyl)-1-nitrosourea treatment induced in syngeneic LSA lymphoma, Journal of Cancer Research and Clinical Oncology New drugs under clinical evaluation in the United States, Cancer Chemotherapy and Pharmacology Streptozocin-based chemotherapy is not history in neuroendocrine tumours, Targeted Oncology Streptozocin-Based Chemotherapy: Still a Standard of Care for Neuroendocrine Tumours?, Management of Neuroendocrine Tumors of the Pancreas and Digestive Tract Inhibition of cellular esterases by the antitumour imidazotetrazines mitozolomide and temozolomide: demonstration by flow cytometry and conventional spectrofluorimetry, Cancer Chemotherapy and Pharmacology Chemotherapy of Carcinomas of the Digestive Tract, Adjuvant Therapies of Cancer Nitrosoureas-Still a Challenge for Developmental Cancer Chemotherapy, Cancer Chemotherapy and Selective Drug Development Pharmacology of Nitrosourea Anticancer Agents, Cancer Chemotherapy and Selective Drug Development Formation and Repair of Adducts that Lead to Cross-Links in DNA Treated with Chloroethylating Agents, DNA Repair Mechanisms and Their Biological Implications in Mammalian Cells Phase II new drug trials in soft tissue sarcomas, Clinical Management of Soft Tissue Sarcomas